• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structural and mechanistic commonalities of amyloid-β and the prion protein.淀粉样蛋白-β和朊病毒蛋白的结构和机制共性。
Prion. 2011 Jul-Sep;5(3):126-37. doi: 10.4161/pri.5.3.17025. Epub 2011 Jul 1.
2
Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease.淀粉样β肽在细胞质膜中的结合位点及其对阿尔茨海默病的影响。
Curr Protein Pept Sci. 2004 Feb;5(1):19-31. doi: 10.2174/1389203043486937.
3
Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease.抗LRP/LR特异性抗体和短发夹RNA(shRNAs)可阻碍阿尔茨海默病中β淀粉样蛋白的脱落。
Sci Rep. 2013;3:2699. doi: 10.1038/srep02699.
4
Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease.淀粉样β肽与神经元和神经胶质细胞质膜的相互作用:结合位点及对阿尔茨海默病的影响
J Pept Sci. 2004 May;10(5):229-48. doi: 10.1002/psc.573.
5
Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity.RAGE-Vd的位点特异性阻断可预防β-淀粉样蛋白寡聚体的神经毒性。
J Neurosci. 2008 May 14;28(20):5149-58. doi: 10.1523/JNEUROSCI.4878-07.2008.
6
Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.晚期糖基化终产物受体的胞外结构域脱落:阿尔茨海默病的一个新的治疗靶点。
Cell Mol Life Sci. 2009 Dec;66(24):3923-35. doi: 10.1007/s00018-009-0121-4.
7
RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.RAGE 通过调节β-和γ-分泌酶活性介导阿尔茨海默病小鼠模型中的 Aβ 积累。
Hum Mol Genet. 2018 Mar 15;27(6):1002-1014. doi: 10.1093/hmg/ddy017.
8
Amyloid-β Receptors: The Good, the Bad, and the Prion Protein.淀粉样β受体:有益的、有害的与朊病毒蛋白
J Biol Chem. 2016 Feb 12;291(7):3174-83. doi: 10.1074/jbc.R115.702704. Epub 2015 Dec 30.
9
Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.外泌体细胞朊蛋白驱动β-淀粉样蛋白的纤维化,并对抗β-淀粉样蛋白介导的神经毒性。
J Neurochem. 2016 Apr;137(1):88-100. doi: 10.1111/jnc.13514. Epub 2016 Mar 2.
10
Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.系统且标准化地比较报告的淀粉样β受体的充足性、亲和力和与阿尔茨海默病的相关性。
J Biol Chem. 2019 Apr 12;294(15):6042-6053. doi: 10.1074/jbc.RA118.006252. Epub 2019 Feb 20.

引用本文的文献

1
Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.晚期糖基化终产物受体(RAGE):免疫疾病的关键枢纽。
Molecules. 2022 Aug 2;27(15):4922. doi: 10.3390/molecules27154922.
2
β-Cleavage of the prion protein in the human eye: Implications for the spread of infectious prions and human ocular disorders.人眼中朊病毒蛋白的β 裂解:对传染性朊病毒传播和人类眼部疾病的影响。
Exp Eye Res. 2021 Nov;212:108787. doi: 10.1016/j.exer.2021.108787. Epub 2021 Oct 7.
3
Downregulation of Candidate Gene Expression and Neuroprotection by Piperine in Streptozotocin-Induced Hyperglycemia and Memory Impairment in Rats.胡椒碱对链脲佐菌素诱导的大鼠高血糖和记忆损伤中候选基因表达的下调作用及神经保护作用
Front Pharmacol. 2021 Mar 2;11:595471. doi: 10.3389/fphar.2020.595471. eCollection 2020.
4
Activation of Mitochondrial Unfolded Protein Response in SHSY5Y Expressing APP Cells and APP/PS1 Mice.在表达APP的SHSY5Y细胞和APP/PS1小鼠中激活线粒体未折叠蛋白反应
Front Cell Neurosci. 2020 Jan 8;13:568. doi: 10.3389/fncel.2019.00568. eCollection 2019.
5
LRP/LR specific antibody IgG1-iS18 impedes neurodegeneration in Alzheimer's disease mice.低密度脂蛋白受体相关蛋白/低密度脂蛋白特异性抗体IgG1-iS18可抑制阿尔茨海默病小鼠的神经退行性变。
Oncotarget. 2018 Jun 5;9(43):27059-27073. doi: 10.18632/oncotarget.25473.
6
Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.β淀粉样蛋白在阿尔茨海默病中的作用靶点——蛋白质加工、脂筏与β淀粉样蛋白孔道
Yale J Biol Med. 2016 Mar 24;89(1):5-21. eCollection 2016 Mar.
7
Looking into laminin receptor: critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein.深入探究层粘连蛋白受体:关于非整合素37/67 kDa层粘连蛋白受体/RPSA蛋白的批判性讨论。
Biol Rev Camb Philos Soc. 2016 May;91(2):288-310. doi: 10.1111/brv.12170. Epub 2015 Jan 28.
8
The 37kDa/67kDa laminin receptor acts as a receptor for Aβ42 internalization.37千道尔顿/67千道尔顿层粘连蛋白受体作为Aβ42内化的受体。
Sci Rep. 2014 Jul 3;4:5556. doi: 10.1038/srep05556.
9
Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease.抗LRP/LR特异性抗体和短发夹RNA(shRNAs)可阻碍阿尔茨海默病中β淀粉样蛋白的脱落。
Sci Rep. 2013;3:2699. doi: 10.1038/srep02699.
10
Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity.抗LRP/LR特异性抗体IgG1-iS18以及通过短发夹RNA(shRNAs)敲低LRP/LR可使细胞免受Aβ42诱导的细胞毒性作用。
Sci Rep. 2013;3:2702. doi: 10.1038/srep02702.

本文引用的文献

1
Neuroprotective therapeutics for Alzheimer's disease: progress and prospects.用于治疗阿尔茨海默病的神经保护疗法:进展与展望。
Trends Pharmacol Sci. 2011 Mar;32(3):141-7. doi: 10.1016/j.tips.2010.12.007. Epub 2011 Jan 20.
2
Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy.阿尔茨海默病始于小血管疾病,由氧化诱导的炎症和失调的淀粉样蛋白代谢损伤引起:对早期检测和治疗的启示。
FASEB J. 2011 Jan;25(1):5-13. doi: 10.1096/fj.11-0102ufm.
3
β-amyloid oligomers and prion protein: Fatal attraction?β-淀粉样寡聚体和朊病毒蛋白:致命吸引?
Prion. 2011 Jan-Mar;5(1):10-5. doi: 10.4161/pri.5.1.14367. Epub 2011 Jan 1.
4
Alimentary prion infections: Touchdown in the intestine.食源性朊病毒感染:在肠道着陆。
Prion. 2011 Jan-Mar;5(1):6-9. doi: 10.4161/pri.5.1.14283. Epub 2011 Jan 1.
5
Decreased clearance of CNS beta-amyloid in Alzheimer's disease.阿尔茨海默病患者中枢神经系统β-淀粉样蛋白清除减少。
Science. 2010 Dec 24;330(6012):1774. doi: 10.1126/science.1197623. Epub 2010 Dec 9.
6
Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.专利生物方法治疗调节 37 kDa/67 kDa 层粘连蛋白受体。
Expert Opin Ther Pat. 2011 Jan;21(1):35-53. doi: 10.1517/13543776.2011.539203. Epub 2010 Nov 27.
7
Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity.淀粉样蛋白细胞毒性中的寡聚体/纤维和细胞膜的生化和生物物理特征。
FEBS J. 2010 Nov;277(22):4602-13. doi: 10.1111/j.1742-4658.2010.07889.x.
8
Tau in Alzheimer disease and related tauopathies.阿尔茨海默病及相关tau 病中的 tau。
Curr Alzheimer Res. 2010 Dec;7(8):656-64. doi: 10.2174/156720510793611592.
9
Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property.阿尔茨海默病β淀粉样蛋白的突触毒性可以用其膜穿孔特性来解释。
PLoS One. 2010 Jul 27;5(7):e11820. doi: 10.1371/journal.pone.0011820.
10
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.tau 的树突功能介导阿尔茨海默病小鼠模型中的淀粉样β毒性。
Cell. 2010 Aug 6;142(3):387-97. doi: 10.1016/j.cell.2010.06.036. Epub 2010 Jul 22.

淀粉样蛋白-β和朊病毒蛋白的结构和机制共性。

Structural and mechanistic commonalities of amyloid-β and the prion protein.

机构信息

School of Molecular and Cell Biology, University of the Witwatersrand, Private Bag 3, Wits 2050, Johannesburg, Republic of South Africa (RSA).

出版信息

Prion. 2011 Jul-Sep;5(3):126-37. doi: 10.4161/pri.5.3.17025. Epub 2011 Jul 1.

DOI:10.4161/pri.5.3.17025
PMID:21862871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3226036/
Abstract

Amyloid β (Aβ) is a major causative agent of Alzheime disease. This neurotoxic peptide is generated as a result of the cleavage of the Amyloid-Precursor-Protein (APP) by the action of beta secretase and gamma secretase. The neurotoxicity was previously thought to be the result of aggregation. However, recent studies suggest that the interaction of Aβ with numerous cell surface receptors such as N-methyl-D-aspartate (NMDA), receptor for advanced glycosylation end products (RAGE), P75 neurotrophin receptor (P75NTR) as well as cell surface proteins such as the cellular prion protein (PrP(c) ) and heparan sulfate proteoglycans (HSPG) strongly enhances Aβ induced apoptosis and thereby contributes to neurotoxicity. This review focuses on the molecular mechanism resulting in Aβ-shedding as well as Aβ-induced apoptotic processes, genetic risk factors for familial Alzheimer disease and interactions of Aβ with cell surface receptors and proteins, with particular emphasis on the cellular prion protein. Furthermore, comparisons are drawn between Alzheimer disease and prion disorders and the role of laminin, an extracellular matrix protein, glycosaminoglycans and the 37 kDa/67 kDa laminin receptor (LRP/LR) have been highlighted with regards to both neurodegenerative diseases.

摘要

β淀粉样蛋白(Aβ)是阿尔茨海默病的主要致病因子。这种神经毒性肽是由β 分泌酶和 γ 分泌酶作用于淀粉样前体蛋白(APP)切割产生的。先前认为神经毒性是聚集的结果。然而,最近的研究表明,Aβ 与许多细胞表面受体(如 N-甲基-D-天冬氨酸(NMDA)受体、晚期糖基化终产物受体(RAGE)、P75 神经营养素受体(P75NTR))以及细胞表面蛋白(如细胞朊病毒蛋白(PrP(c))和硫酸乙酰肝素蛋白聚糖(HSPG))的相互作用强烈增强了 Aβ 诱导的细胞凋亡,从而导致神经毒性。这篇综述重点介绍了导致 Aβ 脱落以及 Aβ 诱导的凋亡过程的分子机制,家族性阿尔茨海默病的遗传风险因素,以及 Aβ 与细胞表面受体和蛋白的相互作用,特别强调了细胞朊病毒蛋白。此外,还比较了阿尔茨海默病和朊病毒病之间的差异,并强调了层粘连蛋白、细胞外基质蛋白、糖胺聚糖以及 37 kDa/67 kDa 层粘连蛋白受体(LRP/LR)在这两种神经退行性疾病中的作用。